Standardized Tablet Coater Offers Cost-Efficiency
Lödige Process Technology introduced the LC light series of tablet coaters that use as standardized design to provide cost-efficient models with faster delivery times than its customized LC series.
The new coater model uses the key technologies found in the LC series, including the air-guiding system, nozzles made by Düsen-Schlick, and a nozzle arm that permits adaptation of the nozzle position to the tablet bed. In the air-guiding system, air flows through a distributor pipe and around the coater drum, entering the drum along a large circumference, which creates an even, low-turbulence air flow in the coater to optimize coating. It also prevents contamination in the coater interior, on the nozzles, or on the nozzle arm. The nozzle arm adjustability allows users to optimize the spraying distance and angle at any time.
Source: Lödige Process Technology
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
